Compare Affirm Holdings Inc (AFRM) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Affirm Holdings Inc vs Novo Nordisk A/S — how do they compare? Affirm Holdings Inc trades at $77.35 (market cap $25.69B), while Novo Nordisk A/S trades at $45.75 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 8.1× Affirm Holdings Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Affirm Holdings Inc pays none. Which is the better fit depends on your goals.
| AFRM | NVO | |
|---|---|---|
Market Cap | $25.69B | $207.85B |
Sector | Financials | Health |
52-Week High | $92.18 | $63.98 |
52-Week Low | $42.53 | $35.29 |
Enterprise Value | $32.30B | $222.55B |
Dividend Yield | — | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Affirm Holdings Inc
Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.
Read more on AFRM →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
